GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth ...
Genscript Biotech Corp (GNNSF) reports a 61.4% revenue surge to $959.5 million, driven by strategic global expansion and key partnerships.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results